OGN
Organon & Co
13.70$
+0.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | +0.5% | -4.2% | +5.7% | +2.6% | +10.1% | +8.6% | -1.8% | |
| – | – | +6.5% | -9.8% | +5.4% | +4.5% | +14.7% | -3.5% | +0.1% | |
| – | – | +30.7% | -96.2% | +6,041.7% | -4.2% | -1.8% | -2.6% | -15.0% | |
| – | – | +30.7% | -96.2% | +6,041.7% | -4.2% | -1.8% | -2.6% | -15.0% | |
| – | – | -1.3% | -10.7% | +7.6% | +6.2% | +15.6% | -19.7% | -3.9% | |
| – | – | +7.7% | -14.8% | +0.2% | +9.6% | +31.1% | +0.5% | +6.4% | |
| – | – | +17.1% | +42.9% | -10.7% | +26.7% | +10.0% | -2.3% | +10.0% | |
| – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +1.7% | -11.3% | |
| – | – | -29.9% | -11.6% | +29.4% | -0.3% | -17.9% | +165.3% | -20.1% | |
| – | – | -15.3% | +31.6% | +163.7% | -2.8% | +2.4% | +4.1% | -4.1% | |
| – | – | -13.2% | +99.3% | -2.8% | -3.3% | +16.2% | -6.9% | -12.1% | |
| – | – | – | -83.3% | +587.5% | +3.6% | -3.5% | +16.4% | -12.5% | |
| – | – | -10.7% | +0.4% | +433.6% | -18.1% | +16.1% | -12.3% | -17.4% | |
| – | – | +105.9% | -100.0% | – | -2.4% | -1.7% | +1.2% | -2.6% | |
| – | – | +10.8% | -22.0% | -127.5% | – | – | – | +59.3% | |
| – | – | – | – | – | – | – | +128.0% | +9.8% | |
| – | +0.0% | +0.0% | +0.2% | +0.0% | +0.6% | +0.4% | +1.1% | +0.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.